Key players in Atopic Dermatitis Treatment
In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.
| # | Company | Website | Our reports |
|---|---|---|---|
| 1 |  Sanofi |
sanofi.com (opens in a new tab) | 1,386 reports |
| 2 |  Regeneron Pharmaceuticals |
regeneron.com (opens in a new tab) | 429 reports |
| 3 |  AbbVie Inc. |
abbvie.com (opens in a new tab) | 1,254 reports |
| 4 |  Pfizer Inc. |
pfizer.com (opens in a new tab) | 2,310 reports |
| 5 |  Eli Lilly and Company |
lilly.com (opens in a new tab) | 1,056 reports |
| 6 | LEO Pharma A/S | — | 99 reports |
Also active in Atopic Dermatitis Treatment
Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.
| Company | Where public records show them |
|---|---|
 Hikma Pharmaceuticals PLC |
|
 Amneal Pharmaceuticals, Inc |
|
| Novitium Pharma | |
| Keymed Biosciences Co.Ltd |
|
| PH Health | |
| Almirall |
|
 Fresenius SE & CO |
|
| Mylan N.V. | |
| Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. |
|
| Jiangsu vcare pharmaceutical technology co., LTD |
|
| Zydus Lifesciences | |
 Aurobindo Pharma |
Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Source: Drugs@FDA, US approvals each company holds for medicines on the market whose FDA label lists this use. Retrieved 13 Nov 2026.
Top trial sponsors in Atopic Dermatitis Treatment
Companies leading the most active studies found with this market's trial search, worldwide (key players included).
- Sanofi 16 active trials on ClinicalTrials.gov (opens in a new tab)
- Pfizer Inc. 14 active trials on ClinicalTrials.gov (opens in a new tab)
- AbbVie Inc. 9 active trials on ClinicalTrials.gov (opens in a new tab)
- Keymed Biosciences Co.Ltd 5 active trials on ClinicalTrials.gov (opens in a new tab)
- Almirall 4 active trials on ClinicalTrials.gov (opens in a new tab)
- Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 4 active trials on ClinicalTrials.gov (opens in a new tab)
- Jiangsu vcare pharmaceutical technology co., LTD 3 active trials on ClinicalTrials.gov (opens in a new tab)
- Qilu Pharmaceutical Co., Ltd. 3 active trials on ClinicalTrials.gov (opens in a new tab)
Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Atopic Dermatitis Treatment reports by place
Australia
Brazil
Canada
China
Ecuador
Egypt
France
Germany
Hong Kong
India
Italy
Japan
Kenya
Malaysia
Mexico
New Zealand
PhilippinesGet the full Atopic Dermatitis Treatment report
Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.
Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.